EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.

2004 • 6,200 citations

A model to predict survival in patients with end-stage liver disease

2001 • 4,580 citations

Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis

2008 • 2,838 citations

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis

1996 • 1,662 citations

Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis

1988 • 1,606 citations

Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis

1999 • 1,592 citations

Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List

2008 • 1,266 citations

Tolvaptan, a Selective Oral Vasopressin V₂-Receptor Antagonist, for Hyponatremia

2006 • 1,163 citations

Compensated cirrhosis: Natural history and prognostic factors

1987 • 1,077 citations

Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis

2007 • 1,061 citations

Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis

2007 • 1,030 citations

Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document

2000 • 1,021 citations

Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis

2002 • 934 citations

The management of ascites in cirrhosis: Report on the consensus conference of the International Ascites Club

2003 • 909 citations

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

1993 • 872 citations

Improved survival after variceal bleeding in patients with cirrhosis over the past two decades

2004 • 822 citations

Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis

1999 • 821 citations

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial

2000 • 791 citations

Renal Failure in Cirrhosis

2009 • 786 citations

Evidence-Based Incorporation of Serum Sodium Concentration Into MELD

2006 • 687 citations

Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in Cirrhosis

2007 • 677 citations

The Serum-Ascites Albumin Gradient Is Superior to the Exudate-Transudate Concept in the Differential Diagnosis of Ascites

1992 • 640 citations

A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal Syndrome

2008 • 634 citations

Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis

1988 • 626 citations

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial

1990 • 621 citations

Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis

1994 • 598 citations

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial

2003 • 596 citations

Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis

1996 • 595 citations

Hyponatremia Treatment Guidelines 2007: Expert Panel Recommendations

2007 • 591 citations

Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized Study

2008 • 581 citations

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study

2002 • 567 citations

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

1999 • 561 citations

Bacterial Infections, Sepsis, and Multiorgan Failure in Cirrhosis

2008 • 535 citations

Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis

2002 • 527 citations

Guidelines on the management of ascites in cirrhosis

2020 • 523 citations

Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-analysis of Individual Patient Data

2007 • 511 citations

Management of adult patients with ascites caused by cirrhosis

1998 • 509 citations

A prospective study of bacterial infections in patients with cirrhosis

1993 • 506 citations

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial

2000 • 482 citations

Factors associated with poor health-related quality of life of patients with cirrhosis

2001 • 480 citations

Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis

2001 • 472 citations

Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites

1988 • 469 citations

Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death

2004 • 469 citations

Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study

2000 • 467 citations

Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites

1987 • 458 citations

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective multicenter study

2002 • 457 citations

Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings

1998 • 456 citations

Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage

1998 • 442 citations

Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial

1996 • 441 citations

Norfloxacin vs Ceftriaxone in the Prophylaxis of Infections in Patients With Advanced Cirrhosis and Hemorrhage

2006 • 438 citations

Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality

1998 • 431 citations

Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: A randomized trial

2004 • 430 citations

A COMPARISON OF PARACENTESIS AND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTING IN PATIENTS WITH ASCITES

2000 • 429 citations

The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension

2005 • 426 citations

The Transjugular Intrahepatic Portosystemic Stent–Shunt Procedure for Refractory Ascites

1995 • 422 citations

The North American Study for the Treatment of Refractory Ascites

2003 • 420 citations

Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems

1998 • 416 citations

Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone

2005 • 412 citations

Hyponatremia in cirrhosis: Results of a patient population survey

2006 • 410 citations

Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome

2004 • 393 citations

Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot study

2002 • 389 citations

Assessment of Prognosis of Cirrhosis

2008 • 387 citations

Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death

2004 • 383 citations

Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club

2005 • 380 citations

Serum sodium predicts mortality in patients listed for liver transplantation

2004 • 380 citations

MELD score and clinical type predict prognosis in hepatorenal syndrome: Relevance to liver transplantation

2005 • 366 citations

Non-peptide arginine-vasopressin antagonists: the vaptans

2008 • 356 citations

Guidelines on the management of ascites in cirrhosis

2006 • 356 citations

Management of adult patients with ascites due to cirrhosis

2004 • 340 citations

Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis

1986 • 339 citations

Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites

2004 • 334 citations

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

1998 • 328 citations

Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features

2006 • 322 citations

Prognostic significance of bacterial infection in bleeding cirrhotic patients: A prospective study

1995 • 319 citations

Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites

1983 • 317 citations

Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage

1992 • 316 citations

Cefotaxime Is More Effective Than Is Ampicillin–Tobramycin in Cirrhotics With Severe Infections

1985 • 308 citations

LONG-TERM SURVIVAL AND RENAL FUNCTION FOLLOWING LIVER TRANSPLANTATION IN PATIENTS WITH AND WITHOUT HEPATORENAL SYNDROME

1991 • 305 citations

Limitations of Serum Creatinine Level and Creatinine Clearance as Filtration Markers in Cirrhosis

1994 • 302 citations

Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding

2010 • 300 citations

Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis

1991 • 300 citations

Paracentesis-induced circulatory dysfunction: Mechanism and effect on hepatic hemodynamics in cirrhosis

1997 • 296 citations

A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: A multicenter, randomized, placebo-controlled trial

2003 • 295 citations

Hyponatremia in cirrhosis: From pathogenesis to treatment

1998 • 294 citations

Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome

2009 • 293 citations

Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: A randomized double-blind multicenter trial

2003 • 286 citations

Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites

1993 • 276 citations

Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease.

1979 • 275 citations

Spontaneous Bacterial Peritonitis in Asymptomatic Outpatients With Cirrhotic Ascites

2003 • 274 citations

Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure

2007 • 268 citations

Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis

1996 • 264 citations

Renal Failure in Patients With Cirrhosis and Sepsis Unrelated to Spontaneous Bacterial Peritonitis: Value of MELD Score

2005 • 257 citations

Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage

1985 • 255 citations

Culture-Negative Neutrocytic Ascites: A Variant of Spontaneous Bacterial Peritonitis

1984 • 246 citations

A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis

2005 • 246 citations

Effect of indomethacin and prostaglandin A, on renal function and plasma renin activity in alcoholic liver disease

1979 • 244 citations

Incidence, Natural History, and Risk Factors of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt With Polytetrafluoroethylene-Covered Stent Grafts

2008 • 242 citations

Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study

2003 • 241 citations

Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.

2006 • 240 citations

Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome

2009 • 239 citations

Transjugular Intrahepatic Portosystemic Stent Shunt: Effects on Hemodynamics and Sodium Homeostasis in Cirrhosis and Refractory Ascites

1995 • 237 citations

Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites

2003 • 232 citations

An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis

2007 • 232 citations

Selective intestinal decontamination prevents spontaneous bacterial peritonitis

1991 • 231 citations

Spontaneous bacterial empyema in cirrhotic patients: A prospective study

1996 • 220 citations

The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt

1997 • 220 citations

Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: Relevance of ascitic fluid protein concentration

1992 • 218 citations

MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation

2007 • 215 citations

Uncovered Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-Analysis

2005 • 212 citations

Trimethoprim-Sulfamethoxazole for the Prevention of Spontaneous Bacterial Peritonitis in Cirrhosis

1995 • 204 citations

Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients.

1993 • 202 citations

Relationship Between Activation of the Sympathetic Nervous System and Renal Blood Flow Autoregulation in Cirrhosis

2007 • 201 citations

Indications for Liver Transplantation

2008 • 200 citations

Prognostic value of spontaneous hyponatremia in cirrhosis with ascites

1976 • 199 citations

Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin

1997 • 198 citations

Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine

1999 • 197 citations

Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial

1998 • 196 citations

Effects of satavaptan, a selective vasopressin V₂receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: A randomized trial

2008 • 195 citations

Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection

1996 • 195 citations

Hyponatremia Impairs Early Posttransplantation Outcome in Patients With Cirrhosis Undergoing Liver Transplantation

2006 • 193 citations

Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage

1994 • 189 citations

Ascites and Renal Dysfunction in Liver Disease

2005 • 185 citations

Compartmentalization of Ascites and Edema in Patients with Hepatic Cirrhosis

1970 • 183 citations

Repeated paracentesis and i.v. albumin infusion to treat ‘tense’ ascites in cirrhotic patients

1987 • 182 citations

Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt

1999 • 181 citations

Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter study

1995 • 177 citations

Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients

2001 • 177 citations

Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease

2005 • 173 citations

Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels

1999 • 173 citations

Spontaneous Bacterial Peritonitis

1997 • 171 citations

Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety

2003 • 171 citations

TIPS versus paracentesis for cirrhotic patients with refractory ascites

2006 • 168 citations

Risk Factors for The Development of Bacterial Infections in Hospitalized Patients With Cirrhosis

1999 • 168 citations

Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral, and hemodynamic parameters

1995 • 162 citations

Dilutional Hyponatremia in Patients With Cirrhosis and Ascites

2002 • 162 citations

Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage.

1982 • 161 citations

Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial*1

1995 • 160 citations

Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients

2000 • 160 citations

Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis

2001 • 160 citations

A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites

2005 • 156 citations

Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage

1986 • 154 citations

Renal failure in cirrhotic patients

2002 • 151 citations

Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis

1991 • 150 citations

Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis

2007 • 149 citations

Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation

2009 • 148 citations

Epidemiology of Severe Hospital‐Acquired Infections in Patients with Liver Cirrhosis: Effect of Long‐Term Administration of Norfloxacin

1998 • 148 citations

Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: A randomized, placebo-controlled study

2008 • 145 citations

The use of vasoconstrictors in patients with cirrhosis: Type 1 HRS and beyond

2006 • 144 citations

Terlipressin for hepatorenal syndrome

2012 • 144 citations

Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial

2009 • 144 citations

Cirrhosis and muscle cramps: Evidence of a causal relationship

1996 • 143 citations

Clinical characteristics and outcome of patients with cirrhosis and refractory ascites

2004 • 142 citations

Single, Total Paracentesis for Tense Ascites: Sequential Hemodynamic Changes and Right Atrial Size

1990 • 141 citations

The Effect of Ciprofloxacin in the Prevention of Bacterial Infection in Patients With Cirrhosis After Upper Gastrointestinal Bleeding

1998 • 140 citations

Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding

2002 • 138 citations

Pentoxifylline Does Not Decrease Short-term Mortality but Does Reduce Complications in Patients With Advanced Cirrhosis

2010 • 135 citations

Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome

2007 • 134 citations

Continuous prazosin administration in cirrhotic patients: Effects on portal hemodynamics and on liver and renal function

1995 • 132 citations

Coagulation disorders in patients with cirrhosis and severe sepsis

2003 • 131 citations

Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis

1994 • 130 citations

Acute effects of the oral administration of midodrine, an ?-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites

1998 • 129 citations

Impact of pretransplant hyponatremia on outcome following liver transplantation

2009 • 127 citations

The impact of serum sodium concentration on mortality after liver transplantation: A cohort multicenter study

2007 • 127 citations

Aminoglycoside nephrotoxicity in cirrhosis

1982 • 125 citations

Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta‐analysis

2005 • 124 citations

Meta‐analysis: terlipressin therapy for the hepatorenal syndrome

2006 • 119 citations

Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites

1994 • 117 citations

Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study

2009 • 117 citations

The hepatorenal syndrome

2001 • 116 citations

Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism

2003 • 113 citations

The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt

1997 • 113 citations

Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding.

2001 • 111 citations

HEPATORENAL SYNDROME

1997 • 110 citations

Acute Effects of Captopril on Systemic and Renal Hemodynamics and on Renal Function in Cirrhotic Patients With Ascites

1985 • 106 citations

Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites

1994 • 106 citations

Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content

1993 • 101 citations

Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid:

2005 • 100 citations

Antidiuretic Hormone and the Pathogenesis of Water Retention in Cirrhosis with Ascites

1994 • 99 citations

Scope of the Problem and Impact on Outcomes

2009 • 99 citations

Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions

2001 • 96 citations

Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites.

1990 • 94 citations

Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture.

1986 • 92 citations

Transjugular intrahepatic portosystemic shunt: Short-term and long-term effects on hepatic and systemic hemodynamics in patients with Cirrhosis

1999 • 92 citations

Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver

1993 • 91 citations

Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trials of spironolactone versus placebo

1997 • 90 citations

A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients

1991 • 87 citations

Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites

2005 • 87 citations

Hepatic neurofibromatosis, malignant schwannoma, and angiosarcoma in von Recklinghausen's disease

1987 • 87 citations

Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study

2000 • 87 citations

Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites

1992 • 87 citations

Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS)

2002 • 86 citations

Risk Factors and Outcome of 107 Patients with Decompensated Liver Disease and Acute Renal Failure (Including 26 Patients with Hepatorenal Syndrome): The Role of Hemodialysis

1995 • 86 citations

Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients.

1996 • 85 citations

Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis

2010 • 82 citations

Ascites and Renal Dysfunction in Liver Disease: Pathogenesis Diagnosis and Treatment

2006 • 82 citations

Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis

1999 • 82 citations

Midodrine Versus Albumin in the Prevention of Paracentesis-Induced Circulatory Dysfunction in Cirrhotics: A Randomized Pilot Study

2008 • 81 citations

Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study

1994 • 79 citations

Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: Comparison of patients with ascites, with refractory ascites, or without ascites

1998 • 78 citations

Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences

1999 • 78 citations

Renal Failure Associated with Demeclocycline in Cirrhosis

1977 • 76 citations

Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance

1990 • 76 citations

Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost

2005 • 75 citations

Salt or no salt in the treatment of cirrhotic ascites: a randomised study.

1986 • 70 citations

Validation of automated blood cell counter for the determination of polymorphonuclear cell count in the ascitic fluid of cirrhotic patients with or without spontaneous bacterial peritonitis

2003 • 69 citations

Should bleeding tendency deter abdominal paracentesis?

2005 • 68 citations

Effects of contrast media on renal function in patients with cirrhosis: A prospective study

2004 • 67 citations

Review article: the utility of reagent strips in the diagnosis of infected ascites in cirrhotic patients

2008 • 64 citations

Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence.

2002 • 63 citations

Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment

2006 • 62 citations

Quality of life in refractory ascites: Transjugular intrahepatic portal-systemic shunting versus medical therapy

2005 • 59 citations

The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients.

2007 • 58 citations

Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?

2006 • 57 citations

Hepatic hydrothorax – pathophysiology, diagnosis and treatment – review of the literature

2004 • 54 citations

Demeclocycline Treatment of Water Retention in Cirrhosis

1976 • 54 citations

The Clinical Course of Patients with Type 1 Hepatorenal Syndrome Maintained on Hemodialysis

2004 • 54 citations

Importance of Plasma Aldosterone Concentration on the Natriuretic Effect of Spironolactone in Patients with Liver Cirrhosis and Ascites

1985 • 53 citations

Factors which influenced postoperative complications in patients with ulcerative colitis or Crohn's disease of the colon on corticosteroids

1978 • 52 citations

[232] ALBUMIN INFUSION FOR SEVERE HYPONATREMIA IN PATIENTS WITH REFRACTORY ASCITES: A RANDOMIZED CLINICAL TRIAL

2007 • 51 citations

Analysis of clinical course and prognosis of culture-positive spontaneous bacterial peritonitis and neutrocytic ascites

1992 • 50 citations

Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease

2009 • 48 citations

Aquaretic effects of niravoline, a κ-opioid agonist, in patients with cirrhosis

2000 • 48 citations

Improved Quality of Life in Patients with Refractory or Recidivant Ascites after Insertion of Transjugular Intrahepatic Portosystemic Shunts

2002 • 48 citations

Clinical trial: short‐term effects of combination of satavaptan, a selective vasopressin V₂ receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia – a randomized, double‐blind, placebo‐controlled study

2010 • 42 citations

Management of Patients with Cirrhosis and Ascites

1986 • 42 citations

Effect of Demeclocycline on Renal Function and Urinary Prostaglandin E<sub>2</sub> and Kallikrein in Hyponatremic Cirrhotics

1984 • 40 citations

New classification with prognostic value in cirrhotic patients.

1989 • 40 citations

The effect of octapressin on renal and intrarenal blood flow in cirrhosis of the liver

1972 • 38 citations

External validation of a prognostic model for predicting survival of cirrhotic patients with refractory ascites1

2002 • 38 citations

Effect of dipyridamole on kidney function in cirrhosis.

1993 • 37 citations

Large Volume Paracentesis and Intravenous Dextran to Treat Tense Ascites

1992 • 30 citations

Vaptans and the Treatment of Water-Retaining Disorders

2006 • 22 citations

Effects of amiloride on renal lithium handling in nonazotemic ascitic cirrhotic patients with avid sodium retention

1992 • 20 citations

Effect of dipyridamole on kidney function in cirrhosis,

1993 • 18 citations

102 EFFECTS OF SATAVAPTAN, AN ORAL VASOPRESSIN V2 RECEPTOR ANTAGONIST, ON MANAGEMENT OF ASCITES AND MORBIDITY IN LIVER CIRRHOSIS IN A LONG-TERM, PLACEBO-CONTROLLED STUDY

2009 • 14 citations

Deleted Work

1955 • 0 citations